Health Trials

Refractory Focal Epilepsy

1

Review clinical trials related to Refractory Focal Epilepsy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Rapport Therapeutics Inc.Updated: Jan 23, 2026Locations: 7
Eligibility criteria

Completion of the associated parent study (RAP-219-FOS-201) treatment period wit... [+6]

Known of hypersensitivity to RAP-219 [+2]

Read more